Hetero Drugs competitive analysis

Explore patent oppositions filed by Hetero Drugs against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
Unitary Pharmaceutical Dosage Form Comprising Tenofovir DfBRISTOL MYERS SQUIBB & GILEAD SCIENCESDec 4, 2015

Latest PTAB cases involving Hetero Drugs

Discover the latest PTAB cases involving Hetero Drugs, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hetero Drugs with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HETERO DRUGS1 - - -
BRISTOL MYERS SQUIBB & GILEAD SCIENCES - 5 - -
GILEAD SCIENCES76386